25 Oct 2020 FDA authorises restart of the COVID-19 AZD1222 vaccine US Phase III trial
23 Oct 2020 Moderna Completes Enrollment of Phase 3 COVE Study of mRNA Vaccine Against COVID-19 (mRNA-1273)
22 Oct 2020 ImmunityBio, NantKwest Announce First Patient Dosed in Phase 1 Clinical Trial of Novel COVID-19 Vaccine Candidate hAd5
22 Oct 2020 GSK presents positive clinical data on maternal and older adults RSV candidate vaccines
21 Oct 2020 Valneva Announces Positive Initial Results for Second Phase 2 Study of Lyme Disease Vaccine Candidate VLA15
21 Oct 2020 Merck Announces Positive Topline Results from Two Additional Phase 3 Adult Studies Evaluating V114, Merck’s Investigational 15-valent Pneumococcal Conjugate Vaccine
21 Oct 2020 Affinivax Announces the Presentation of Phase 1 Clinical Data for its MAPS™ Vaccine for Streptococcus pneumoniae at IDWeek 2020
19 Oct 2020 Ultimovacs Announces Updated Positive Results from Phase I Trial Evaluating Universal Cancer Vaccine, UV1, in Non-Small Cell Lung Cancer
16 Oct 2020 FDA Authorizes Phase 1 Trial of ImmunityBio’s Novel COVID-19 Vaccine Candidate hAd5; Dual Construct is Designed to Drive Both T Cell and Antibody Immunity
15 Oct 2020 Sanofi and Translate Bio mRNA COVID-19 Vaccine Candidate Induced High Antibody Levels in Preclinical Studies
14 Oct 2020 Vaxart Announces Positive Hamster Challenge Study Data for its Oral COVID-19 Vaccine
14 Oct 2020 Medigen's COVID-19 Vaccine Combined with Dynavax's CpG 1018 Adjuvant Receives Taiwan Government Subsidy with First Participant Dosed in Early October
13 Oct 2020 Lineage Cell Therapeutics and Cancer Research UK Announce Encouraging Preliminary Phase 1 Study Results With VAC2 for the Treatment of Non-small Cell Lung Cancer
13 Oct 2020 Moderna Announces Initiation of Rolling Submission to Health Canada for mRNA Vaccine Against COVID-19 (mRNA-1273)
13 Oct 2020 Johnson & Johnson Temporarily Pauses All Dosing in Our Janssen COVID-19 Vaccine Candidate Clinical Trials
08 Oct 2020 Moderna Announces Updates on Respiratory Syncytial Virus (RSV) Vaccine Program
08 Oct 2020 IMV Provides Updates On COVID-19 Vaccine Program
07 Oct 2020 Janpix Announces $10 Million Series B Financing to Advance STAT Protein Degrader Pipeline
06 Oct 2020 China Biotech Services (8037.HK) and National Institute for Viral Disease Control and Prevention (NIVDC) to develop Genetically Engineered Recombinant Vaccine for COVID-19
06 Oct 2020 Promising Phase II results underpin GemVax decision to apply for expanded access IND for GV1001 in Alzheimer's Disease
06 Oct 2020 BioNTech and Pfizer Initiate Rolling Submission to European Medicines Agency for SARS-CoV-2 Vaccine Candidate BNT162b2
02 Oct 2020 Impact BioMedical to Begin Efficacy Testing of Pan-Coronavirus Vaccine Under New Wholly Owned Subsidiary Innate Immune, Inc.
02 Oct 2020 EMA starts first rolling review of a COVID-19 vaccine in the EU
02 Oct 2020 COVID-19 vaccine AZD1222 clinical trial resumed in Japan, follows restart of trials in the UK, Brazil, South Africa and India
01 Oct 2020 Vaccibody enters into worldwide license and collaboration agreement with Genentech, a member of the Roche Group, to develop individualized neoantigen cancer vaccines

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2020 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up